Blink Intensive Tears Plus (10 ml)

Blink® intensive tears PLUS

Instructions for use / Package leaflet

Intense gel liquid: eye drops 10ml  

Long-term relief from persistent dryness and irritated eyes.

A more viscous formulation that provides lasting relief from persistent dry sensations, irritated eyes. Recommended for both day and night use.

Advice (when to use)For irritated, uncomfortable sensations.

Contraindications:No known contraindications.

Instructions for use:
Place 1 or 2 drops in the affected eye as needed. Blink several times to flush the eye.
Use as often as you feel the need.

Precautions:

• Vision may blur immediately after using the eye drops. Wait until this effect wears off and you can see clearly again.


• We recommend that you remove contact lenses before use and replace them once the temporary blurring of vision has resolved.


• Do not use if gasket is damaged or missing.


• Do not swallow the solution.


• Do not use if allergic to any of the ingredients.


• To avoid contamination, do not touch the tip of the bottle on any surface and avoid getting it in your eyes.


• Do not use after the expiry date.


• Keep out of the reach of children.


• Store between 5°C and 25°C.


• Discard any remaining solution 45 days after first opening the bottle.

Potential risks, side effects or complications associated with eye drops in general:
Allergic reaction, inflammatory reaction or infection:
Do not use if you have any problems.

Adverse reactions:No known side effects.

Ingredients: Polyethylene glycol 400 (PEG 400) - 0.25% OcuPure® preservative (sodium chlorite) sodium hyaluronate - 0.38%,Boric acid, Sodium borate, Sodium chloride, Potassium chloride, Calcium chloride, Magnesium chloride, Purified water

Manufacturer: Johnson & Johnson Surgical Vision, Inc.

STERIL A
CE 0123
Manufacturer: AMO Ireland, Block B, Liffey Valley Office Campus
Quarryvale, Co. Dublin, Ireland
blink, blink contacts and OcuPure are trademark oj Johnson & Johnson Surgical Vision, Inc.
© Johnson & Johnson Surgical Vision, Inc. 2018

AM70515AX12D
Last revision date of the information sheet: April 2018.